| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.sanofiindialtd.com | |
| Market Cap | 19,064.98 Cr. | |
| Enterprise Value(EV) | 18,658.48 Cr. | 2023-12 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 261.78 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 31.62 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.99 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 411.16 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 20.13 | Calculated using Price: 8,278.10 |
| Dividend Yield | 2.02 | Period Ending 2023-12 |
| No. of Shares Subscribed | 2.30 Cr. | 23,030,622 Shares |
| FaceValue | 10 | |
| About Sanofi India Ltd. | ||
| The company is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. The company prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. The company stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. | ||
| 1 Day |
|
+1.48% |
| 1 Week |
|
-2.52% |
| 1 Month |
|
+8.74% |
| 3 Month |
|
-0.79% |
| 6 Month |
|
+10.72% |
| 1 Year |
|
+38.46% |
| 2 Year |
|
+18.50% |
| 5 Year |
|
+47.35% |
| 10 Year |
|
+176.11% |
| 3 years | 2003-12 | 2004-12 | 2023-12 | |
| Return on Equity (%) | 31.91 | 40.83 | 87.18 | |
| Return on Capital Employed (%) | 45.43 | 59.81 | 115.15 | |
| Return on Assets (%) | 21.1 | 28.32 | 22.71 |
| Particulars | 3 years | 2003-12 Rs. Cr. | 2004-12 Rs. Cr. | 2023-12 Rs. Cr. |
| Shh. Funds | 346 | 454 | 1,015 | |
| Non Curr. Liab. | 16 | 21 | 1,153 | |
| Curr. Liab. | 133 | 131 | 2,535 | |
| Minority Int. | ||||
| Equity & Liab. | 496 | 606 | 4,703 | |
| Non Curr. Assets | 180 | 170 | 1,571 | |
| Curr. Assets | 316 | 435 | 3,131 | |
| Misc. Exp. not W/O | ||||
| Total Assets | 496 | 606 | 4,703 |
| Particulars | 3 years | 2003-12 Rs. Cr. | 2004-12 Rs. Cr. | 2023-12 Rs. Cr. |
| Net Sales | 657 | 743 | 2,851 | |
| Other Income | 14 | 20 | 67 | |
| Total Income | 671 | 762 | 2,918 | |
| Total Expenditure | -503 | -511 | -2,049 | |
| PBIDT | 168 | 251 | 869 | |
| Interest | 0 | 0 | -2 | |
| Depreciation | -19 | -19 | -40 | |
| Taxation | -51 | -83 | -243 | |
| Exceptional Items | 7 | 7 | 18 | |
| PAT | 105 | 156 | 603 | |
| Minority Interest | ||||
| Share Associate | ||||
| Other Related Items | ||||
| Consolidated Net Profit | 105 | 156 | 603 | |
| Adjusted EPS | 45 | 68 | 262 |
| Particulars | 1 years | 2023-12 Rs. Cr. |
| Cash Fr. Operatn. | 230 | |
| Cash Fr. Inv. | 38 | |
| Cash Fr. Finan. | -878 | |
| Net Change | -610 | |
| Cash & Cash Eqvt | 395 |
|
Fri, 26 Apr 2024
Board Meeting Intimation SANOFI INDIA LIMITED has informed the Exchange about Board Meeting to be held on 13-May-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended March 2024 . |
|
Tue, 23 Apr 2024
Copy of Newspaper Publication Sanofi India Limited has informed the Exchange about Copy of Newspaper Publication |
|
Mon, 22 Apr 2024
Loss of Share Certificates Sanofi India Limited has informed the Exchange about Loss of Share Certificates |
| Fri, 26 Apr 2024 |
Opening at Low
|
Closing Above Previous High
|
Close Within 52 Week High Zone
|
High Increase in 1 Month
|
High Increase in 1 Year
|
